Jana Medical Company
Initial Public Offering
Invest in the Future of the Kingdom's Health
Jana Medical Company was established in 2015, and it specializes in the medical sector by providing medical supplies and devices for cardiac surgeries, brain and nerve surgery, spine surgery, respiratory therapy supplies, anesthesia, and supplying ear, nose and throat supplies. Jana provides service for public and private entities and hospitals throughout the Kingdom of Saudi Arabia thank to the close relationships Jana has established with the most important clients and global brands.
About Us
Jana Medical Company
Jana's Vision
To lead pioneering companies in the field of medical devices and supplies by working to provide high-quality medical solutions and technologies, and contributing to the development of new and more beneficial methods for medical service providers that help them provide their services to the public in the best and safest way.
Jana's Mission
Facilitate access to the latest and safest medical technologies and devices of international quality, and provide them to medical service providers.
Jana Strategy
The company's strategy revolves around three main axes:
Strengthening and developing the company's main business
Through continuous expansion and development by providing the best integrated medical solutions and innovative healthcare technologies for all therapeutic fields in the Kingdom.Supporting the transformation strategy for the health sector in line with Saudi Vision 2030:
Through effective and essential participation in public-private partnership initiatives, and providing support services for these partnerships such as management and maintenance services for medical devices, radiology diagnostic centers and laboratories, and localizing industries related to the health sector.
Investing in health services and medical technology through
- Oncology treatment service centers in accordance with the highest international standards
- Radiology diagnostic centers and laboratories according to the latest scientific technologies
- Same-day surgery centers with various specialties
- Virtual healthcare platforms and remote medical communication
Subsidiaries
Jana Industry Company
Elite Care Medical Company
Excellent Care Medical Company
Jana Medical Company CEO
Jamil Muthib Waqian Al-Otaibi
Our journey towards growth and innovation began in 2015. Today, Jana continues the journey as a trusted partner in the healthcare sector in the Kingdom of Saudi Arabia, providing solutions in high-quality medical devices and supplies to the public and private sectors. As the Kingdom continues its economic transformation under Saudi Vision 2030, Jana is well positioned to play a prominent role in the development of the healthcare industry.
Some details
Medical Jana in numbers
Offering Information
Ownership Structure Pre and Post Offering
| Shareholder Name | Pre-Offering | Post-Offering | |||||||||
| Directly | Indirectly | Directly | Indirectly | ||||||||
| Number of shares | % | Number of shares | % | Number of shares | % | Number of shares | % | ||||
| Jana Investment Holding Company | 412,732 | 16.06% | - | - | 412,732 | 12.85% | - | - | |||
| Eid Sultan Ayed Al Otaibi | 360,269 | 14.02% | 408,605 | 15.90% | 360,269 | 11.21% | 408,605 | 12.72% | |||
| Miteb Sultan Ayed Al Otaibi | 8,888 | 0.35% | 4,127 | 0.16% | 8,888 | 0.28% | 4,127 | 0.13% | |||
|
Other shareholders who do not meet the definition of the public, each of whom owns less than 5%, (7) shareholders. |
238,889 | 9.29% | - | - | 238,889 | 7.44% | - | - | |||
|
Shareholders who meet the definition of the public , each of whom owns less than 5%, 814 shareholders |
1,549,222 | 60.28% | - | - | 1,549,222 | 48.22% | - | - | |||
| New Qualified Investors | -- | -- | -- | -- | 642,500 | 20.00% | -- | -- | |||
| Total | 2,570,000 | 100% | 412,732 | 16.06% | 3,212,500 | 100% | 412,732 | 12.85% | |||
Offering Information
Expected Timeline for the Offering
(642,500) ordinary shares with a nominal value of (10) Saudi Riyals per share will be offered for public subscription in the parallel market (Nomu), by increasing the company's capital from (25,700,000) Saudi Riyals to (32,125,000) Saudi Riyals by issuing (642,500) new shares, representing (20%) of the company's total issued capital after the capital increase (which represents (25%) of the company's issued capital before the capital increase.
Offering Information
Frequently Asked
Questions
Jana Medical Company imports, supplies and sells medical devices, equipment and supplies, which are medical equipment, devices and supplies that fall under the following departments: (Cardiovascular - General and Microsurgery - Neck and Spine - Pain Management - Projects and Maintenance).
Jana Medical Company aims through the IPO to enhance the company's growth and focus on future expansion and growth by implementing new projects that will positively reflect on its position and market value.
The offering is limited, according to the requirements of the Rules on the Offer of Securities and Continuing Obligations, to the categories of qualified investors according to the definition of the qualified investor in the glossary used in the regulations and rules of the Capital Market Authority, which means in Chapter Eight of the rules for offering securities and ongoing obligations, any of the following: 1. Capital market institutions acting on their own account. 2. Clients of a capital market institution licensed to practice management business, provided that the capital market institution has been appointed on terms that enable it to make decisions regarding accepting participation in the offering and investing in Nomu – Parallel Market on behalf of the client without the need to obtain prior approval from it. 3. The Kingdom’s government, any governmental body, any international body recognized by the Authority, the market, any other capital market recognized by the Authority, or the Securities Depository Center Company (“Edaa”). 4. Companies owned by the government, directly or through a portfolio managed by a capital market institution licensed to practice management business. 5. Companies and funds established in the Gulf Cooperation Council countries. 6. Investment funds. 7. Any other legal persons who may open an investment account in the Kingdom and an account with Edaa. 8. Natural persons who may open an investment account in the Kingdom and an account with Edaa provided that any of the following criteria are met: a) He has conducted transactions in the stock markets with a total value of no less than forty million Saudi Riyals and no less than ten transactions in each quarter during the past twelve months. b) His net assets value is no less than five million Saudi Riyals. c) He works or has previously worked for at least three years in the financial sector. d) He has obtained the general certificate for dealing in securities approved by the Authority "CME-1". e) He has obtained a professional certificate specialized in the field of securities business approved by an internationally recognized body. f) Any other persons determined by the Authority.
The minimum subscription is 10 shares, and the maximum is 157,412 shares for each qualified investor.
The shareholder is entitled to his share of the profits in accordance with the General Assembly resolution issued in this regard. The resolution shall specify the due date and the distribution date. The right to profits shall be for the shareholders registered in the shareholders’ records at the end of the due date. The offering shares shall be entitled to their share of any profits announced by the company as of the offering date and for the following financial years.
Yes, substantial shareholders who own five percent or more of the company’s shares will be subject to a lock-up period of (12) twelve months from the date of commencement of trading in the parallel market.
The price range will be determined based on the order book building process and the evaluation of demand by qualified investors and in coordination between the company and the lead manager.
The net proceeds of the offering, after deducting related expenses, will be used to achieve many ambitious plans to the maximum possible benefit to the company and shareholders, and shareholders will not receive any part of the proceeds of the subscription.
The company's shares are expected to start trading in the market shortly after the completion of the share allocation process.
Financial Advisor and Underwriting Manager
Receiving Entities
